SIHUAN Pharmaceuticals
subsidiary, Hainan Sihuan
Pharmaceutical, has signed a 30
year exclusive agreement with
Benxi Leilong Pharmaceutical to
distribute the latter’s Alprostadil
Injection to Sihuan
Pharmaceutical’s distribution
network of close to 10,000
hospitals in China.
The Alprostadil Injection is one
of the best-selling cardio-cerebral
vascular drugs in China and is an
intravenous injectable lipid emulsion
for treatment of peripheral
vascular diseases, cardio-cerebral
microcirculation disorders and
post-surgery thrombosis.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Nov 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Nov 10
MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.